Health Care/Hospital
Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative
MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...
2022-04-06 19:37
2353
Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors
HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...
2022-04-06 17:10
2219
Alex Therapeutics raises €3.5M in oversubscribed financing round from top tier VC investors to advance expansion in Europe and the US.
STOCKHOLM, April 6, 2022 /PRNewswire/ -- Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a€3.5M funding round, led by European life science venture fund Hadean Ventures and joined by Scale Capital and Bonit Capital. Alex Therapeutics aspires to...
2022-04-06 14:20
1594
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2022-04-06 12:43
2902
VISTA Eye Specialist (VISTA) introduces cutting-edge Swiss Technology for Cataract Surgery, giving patients a simple, fast and safe procedure.
PETALING JAYA, Malaysia, April 6, 2022 /PRNewswire/ -- VISTA is always looking to provide the latest technology availablefor Cataract patients - making the surgery simpler and improve the result, safety and comfort - not just for the patient but also the surgeon. Having Robotic Computer-aided tec...
2022-04-06 09:11
2417
Cambridge Nutranostics has developed a point-of-care prototype of OCCL test for testing blood plasma oxygen to monitor health in post stroke and TIA patients for dementia prevention
CAMBRIDGE, England, April 6, 2022 /PRNewswire/ -- Cambridge Nutranostics Ltd,
CNL,http://occltest.com
2022-04-06 09:00
1381
Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals
Discovery-based pharmaceutical company in Japan leverages Cloudera for greater speed to insights across its research, development, and post-market value chain. SINGAPORE, April 6, 2022 /PRNewswire/ -- Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company,Sh...
2022-04-06 08:00
2452
Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis
SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today t...
2022-04-06 08:00
2036
Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business
NEW YORK, April 6, 2022 /PRNewswire/ -- Mindtree
2022-04-06 07:13
1846
Digital Engagement Continues to Soar Amongst Biopharmas in APAC
SYDNEY, April 6, 2022 /PRNewswire/ -- Veeva Systems
2022-04-06 05:00
2616
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK
LONDON, April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd.
2022-04-05 14:00
2132
Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions
SINGAPORE, April 5, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients...
2022-04-05 13:30
2683
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNew...
2022-04-05 13:00
2257
TraceLink Launches its Opus Compliance Framework with the Release of the Brazil Compliance Solution on the Opus Platform
The Opus™ Compliance Framework Enables Rapid Development of Compliance Solutions To Keep Pace With Increasing Country Mandates BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company, announces the release of its Opus™ Compliance Framework with the relea...
2022-04-05 13:00
1623
Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols
JAKARTA, April 5, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming
G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series
that took place on28-30 March 2022 in Yogyakarta, Indonesia.
2022-04-05 09:00
3193
Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis
HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics
2022-04-04 21:31
2687
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals
Deals mark an important step toward AMR Action Fund's goal of bringing two to four new antibiotics to market to take on growing threat of drug-resistant bacteria BOSTON, April 4, 2022 /PRNewswire/ -- The AMR Action Fund, the world's largest public-private partnership investing in biotech compani...
2022-04-04 18:00
2061
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province
HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets inZhejiang Province has been completed. On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"),...
2022-04-04 17:10
2495
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia
BANGKOK, April 4, 2022 /PRNewswire/ -- SeaX Ventures (Southeast Asia Exponential Ventures) announced today the close of its second fund to help accelerate the growth of global startups throughoutSoutheast Asia. The fund is dedicated to investing in companies working on truly transformational opp...
2022-04-04 16:00
5691
International Virchow Prize for Global Health launched
Highly prestigious award endowed with €500,000 to uphold the United Nations
2030 Agenda
- Picture is available at AP Images (http://www.apimages.com
2022-04-04 16:00
1510
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
